Back to News
Market Impact: 0.15
Two Biotechs Get Beaten Down: Jaguar Health Collapses 59%, Viking Therapeutics Sinks 4%
Source: 247wallst.com
Healthcare & Biotech

Jaguar Health (NASDAQ: JAGX) was lower in Wednesday morning trading, alongside another biotechnology stock for unrelated reasons. The broader biotechnology sector was not selling off, indicating the declines were company-specific; the provided article text does not specify the magnitude or catalyst for Jaguar Health's move.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
JAGX-0.20
More News
- Street Calls of The Week
- argenx reports positive phase 3 data for autoimmune myositis drug
- Why the prognosis for healthcare stocks is uncertain ahead of Congress’ new makeup
- AtriCure: A New Quality Metric Could Put A Clip In Nearly Every Sternotomy
- J&J presents patient data on nipocalimab for Sjögren’s disease
- Rent-a-grandchild: Businesses offering companions to elderly grow in India